相关实验视频
Updated: May 30, 2025

A Preclinical Model of Exertional Heat Stroke in Mice
Published on: July 1, 2021
潜在的西萨特拉诱导的恶性高温症:一个病例报告
Sinen Zeleke1, Victoria L Watson1, Catherine Adams2
1Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
恶性高温症是一种罕见的药物遗传性疾病,可以由非分极神经肌肉阻断剂 (如cisatracurium) 触发. 这一案例凸显了考虑这种罕见的超代谢危机的原因,以及时给予丹特罗林的重要性.
科学领域:
- 药物遗传学 药物遗传学
- 麻醉学 麻醉学
- 临界护理医学 临界护理医学
背景情况:
- 恶性高温症是一种危及生命的药物遗传性疾病.
- 它通常与去极化神经肌肉阻断剂有关.
- 与非去极化剂相关的病例很少被记录下来.
研究的目的:
- 报告一种罕见的恶性高温症病例.
- 为了确定cisatracurium作为一个潜在的触发器.
- 为了强调高温症的差异诊断.
主要方法:
- 一个57岁的男性患者的病例报告.
- 体积过载和ARDS的临床表现.
- 给药的cisatracurium和随后的高温症.
- 纳兰乔评分用于药物不良反应评估.
主要成果:
- 患者在注射cisatracurium后出现恶性高温症.
- 核心体温上升到109°F.
- 纳拉尼奥得分表明cisatracurium是可能的原因.
- 丹特罗伦的使用导致了温度的改善.
结论:
- 非去极化神经肌肉阻断剂,如cisatracurium,可以导致恶性热升高.
- 这种罕见的不良药物反应需要迅速识别.
- 考虑到患有无法解释的温度升高的患者的恶性高温症对于及时干预丹特烯至关重要.
更多相关视频
06:43Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Increased Body Temperature
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...